Detailed health profiling for people with PCOS
Phenotyping of Patients With Polycystic Ovary Syndrome (PCOS) in Alsace, France
University Hospital, Strasbourg, France · NCT07339930
This effort will collect clinical, hormonal (including AMH), and imaging information from adult women seen at Strasbourg University Hospital with suspected or confirmed PCOS to try to better define PCOS types.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 49 Years |
| Sex | All |
| Sponsor | University Hospital, Strasbourg, France (other) |
| Locations | 1 site (Strasbourg) |
| Trial ID | NCT07339930 on ClinicalTrials.gov |
What this trial studies
This observational project will enroll adult women (18–49 years) who consult the Endocrinology department at CHU de Strasbourg for suspected PCOS or are found to have PCOS during endocrine care. Participants will have standardized collection of medical history, menstrual and reproductive data, hormone measurements including anti-Müllerian hormone (AMH), pelvic ultrasound morphology, and screening for metabolic risk and mood symptoms. No treatments are given as part of the protocol; data will be analyzed to identify clinical and biochemical phenotypes and how they relate to current diagnostic criteria. The aim is to reduce diagnostic delay and clarify feature clusters that could guide more personalized management in the future.
Who should consider this trial
Good fit: Adult women aged 18 to under 50 who consult the Endocrinology department at Strasbourg University Hospital with suspected PCOS or who are found to have PCOS during evaluation.
Not a fit: People whose final diagnosis excludes PCOS, those younger than 18 or 50 and older, and those unable to attend CHU de Strasbourg appointments will not directly benefit from participation.
Why it matters
Potential benefit: If successful, this could help clinicians diagnose PCOS earlier and tailor care to specific PCOS subtypes, potentially improving fertility and metabolic management.
How similar studies have performed: Numerous prior observational cohorts have characterized PCOS phenotypes and supported AMH and ultrasound as useful markers, so this study builds on established but still-evolving evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult woman (≥18 years and \<50 years) * Subject who consulted at the Strasbourg University Hospitals for suspected PCOS or for any other endocrinological condition that led to the discovery of PCOS. Exclusion Criteria: * Final diagnosis excluding PCOS.
Where this trial is running
Strasbourg
- ervice d'Endocrinologie, Diabétologie et Nutrition - CHU de Strasbourg - France — Strasbourg, France (RECRUITING)
Study contacts
- Study coordinator: Thibault BAHOUGNE, MD
- Email: thibault.bahougne@chru-strasbourg.fr
- Phone: 33 3.88.12.78.99
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Polycystic Ovary Syndrome, Polycystic ovary syndrome, Polycystic Ovary, Endocrine disorder, Menstrual cycle disorders, Anti-Müllerian hormone